AzTrials
AzTrials

Low Back PainNCT07832422

Ischemic Compression and Low-Level Laser Therapy for Myofascial Low Back Pain

A study testing Ischemic Compression, Low-Level Laser Therapy and Exercise Program in people with Low Back Pain and Myofascial Pain Syndromes, run by Nova Southeastern University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

This randomized controlled study will compare the effects of ischemic compression combined with exercise, low-level laser therapy combined with exercise, and sham low-level laser therapy combined with exercise in adults with subacute or chronic myofascial low back pain. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Low Back Pain, Myofascial Pain Syndromes
What is being tested?
Ischemic Compression, Low-Level Laser Therapy and Exercise Program
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
45 participants
Where
1 siteUnited States
Study dates
Sep 2026to Apr 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18-80 years
  • Diagnosis of myofascial low back pain
  • Presence of active myofascial trigger point(s) in the lumbar region
  • Ability to understand and follow study procedures
  • Willingness to participate and provide written informed consent

Who cannot join

  • Pregnancy or lactation
  • Photosensitivity or known sensitivity to light-based therapy
  • Pacemaker use
  • Malignancy or suspected malignancy, particularly in the treatment area
  • Skin lesions, active infection, or open wounds in the lumbar treatment area
  • History of lumbar spine surgery or spinal fracture
Show all 11Show fewer
  • Neurological disorders that may affect study participation or outcome assessment
  • Serious systemic disease that may interfere with participation or treatment safety
  • Current physical therapy treatment for low back pain
  • Corticosteroid injection within the previous 3 months
  • Any contraindication to low-level laser therapy or ischemic compression

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

KHALID G ATTIA, PT, DPT contact

646-641-1881

ka1523@mynsu.nova.edu

United States1 site
  • Attia Rehabilitation Pt Pc

    Brooklyn, New York, 11235

    KHALID G ATTIA, PT, DPT, 347-374-3371, KHALIDATTIA2017@GMAIL.COM

    KHALID G ATTIA, PT, DPT

Other trials in United States

About this study

Official title: Effects of Ischemic Compression and Low-Level Laser Therapy in Combination With Exercise Versus Exercise Alone in Managing Myofascial Low Back Pain: A Randomized Controlled Study

This randomized controlled study will compare the effects of ischemic compression combined with exercise, low-level laser therapy combined with exercise, and sham low-level laser therapy combined with exercise in adults with subacute or chronic myofascial low back pain. Participants will be assigned to one of three treatment groups. Outcomes will include pain intensity measured using the Visual Analog Scale (VAS), pressure pain threshold (PPT), and disability measured using the Oswestry Disability Index (ODI). Outcomes will be assessed at baseline, 3 weeks, 6 weeks, and at a 1-month follow-up.

Read the detailed description

This study is a randomized controlled trial designed to evaluate and compare three physical therapy interventions for adults with subacute or chronic myofascial low back pain. Participants will be assigned to one of three groups: ischemic compression combined with exercise, low-level laser therapy combined with exercise, or sham low-level laser therapy combined with exercise. The study will evaluate changes in pain intensity, pressure pain threshold, and low back pain-related disability. Outcome measures will include the Visual Analog Scale (VAS), pressure pain threshold (PPT), and Oswestry Disability Index (ODI). Measurements will be obtained at baseline, after 3 weeks of treatment, after 6 weeks of treatment, and at a 1-month follow-up.

Being tested
Ischemic Compression, Low-Level Laser Therapy, Exercise Program, Sham Low-Level Laser Therapy
Keywords
Myofascial Pain, Low Back Pain, Ischemic Compression, Low-Level Laser Therapy, Exercise Therapy, Myofascial Trigger Points
Medical subject headings
Low Back Pain, Myofascial Pain Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ischemic CompressionOther

    Ischemic compression will be applied to identified myofascial trigger points in the lumbar region in combination with the prescribed exercise program.

  • Low-Level Laser TherapyDevice

    Low-level laser therapy will be applied to identified myofascial trigger points in the lumbar region in combination with the exercise program according to the study protocol.

  • Exercise ProgramOther

    Participants will perform a standardized therapeutic exercise program designed to improve lumbar mobility, flexibility, strength, and functional performance according to the study protocol.

  • Sham Low-Level Laser TherapyDevice

    The laser probe will be applied to identified lumbar myofascial trigger points in the same manner and for the same duration as active low-level laser therapy, but with the laser power deactivated and no laser energy delivered.

Study groups in NCT07832422
Study groupRoleWhat they receive
Ischemic Compression Plus ExerciseExperimentalParticipants assigned to this group will receive ischemic compression in combination with an exercise program.
Receives: Other: Ischemic Compression; Other: Exercise Program
Low-Level Laser Therapy Plus ExerciseExperimentalParticipants assigned to this group will receive low-level laser therapy in combination with an exercise program.
Receives: Device: Low-Level Laser Therapy; Other: Exercise Program
Sham Low-Level Laser Therapy + Exercise.Active comparatorParticipants assigned to this group will receive sham low-level laser therapy, with the laser device applied to identified lumbar myofascial trigger points in the same manner and for the same duration as active LLLT, but with no laser energy delivered, followed by the standardized therapeutic exercise program.
Receives: Other: Exercise Program; Device: Sham Low-Level Laser Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Intensity Measured by Visual Analog Scale (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS), with scores ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Lower scores indicate less pain.

    Measured: Baseline, 3 weeks, 6 weeks, and 1-month follow-up

Secondary outcomes (3)
  1. Functional Disability Measured by the Oswestry Disability Index (ODI)

    Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI). The ODI score ranges from 0% to 100%, with higher scores indicating greater disability.

    Measured: Baseline, 3 weeks, 6 weeks, and 1-month follow-up

  2. Pressure Pain Threshold (PPT)

    Pressure pain threshold will be assessed using a pressure algometer over identified myofascial trigger points in the lumbar region. Higher PPT values indicate greater pressure tolerance and reduced mechanical pain sensitivity.

    Measured: Baseline, 3 weeks, 6 weeks, and 1-month follow-up

  3. Global Rating of Change (GROC)

    Perceived overall change in health status will be assessed using the Global Rating of Change (GROC), a single-item patient-reported measure ranging from worsening to improvement. Higher scores indicate greater perceived improvement.

    Measured: 3 weeks, 6 weeks, and 1-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionMar 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of three parallel intervention groups: ischemic compression plus exercise, low-level laser therapy plus exercise, or sham low-level laser therapy plus exercise.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07832422
Sponsor's protocol ID
2026-403-NSU
Status last verified
Sep 2026
First submitted
16 Sep 2026
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Individual participant data will not be shared to protect participant confidentiality and privacy. Aggregate study results may be reported in the dissertation and subsequent scientific publications.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in